4 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 4, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow Group A: new trials by email Literature Review of Group A trials Research Report on Group A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU. Placebo drug ( normal saline ), neostigmine (reversal agent) - Tachycardia, Hypertension | Phase 1 / Phase 2 | Completed | Ziauddin University | 100 | 2025-03-12 | 2025-07-31 |
| Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants Group A, Reference Group - Bioequivalence | Phase 1 | Not yet recruiting | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 110 | 2025-02-01 | 2025-02-17 |
| Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome Vitamin D, Active Comparator - Anovulatory Infertility | Phase 1 | Recruiting | Aga Khan University | 142 | 2024-01-01 | 2026-11-04 |
| Alleviation of Common Cold Symptoms Wintergreen Throat Spray and Aspirin Tablet, Aspirin Throat Spray and Placebo Tablet, Wintergreen Throat Spray and Placebo Tablet - Common Cold, Pharyngitis | Phase 1 | Completed | Applied Biological Laboratories Inc | 157 | 2022-05-25 | 2024-01-16 |
| Radiofrequency, Perineural Injection, Idiopathic Carpal Tunnel Syndrome mehylprednisolone injection, pulsed radiofrequency (PRF), platelet-rich plasma - Carpal Tunnel Syndrome | Phase 1 | Unknown | Alexandria University | 75 | 2018-09-01 | 2021-09-29 |
| A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer MM-398, Irinotecan, Leucovorin (LV) - Unresectable Advanced Cancer | Phase 1 | Completed | GERCOR - Multidisciplinary Oncology Cooperative Group | 10 | 2015-11-18 | 2017-01-31 |
| A Study of the Safety and Efficacy of EBV Specific T-cell Lines Group A, Group B - Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder | Phase 1 / Phase 2 | Completed | Dr. Jean-Sebastien Delisle, MD, PhD | 12 | 2015-11-01 | 2025-05-14 |
Carpal Tunnel Syndrome (1) · Common Cold (1) · Cough (1) · Delayed Emergence from Anesthesia (1) · Epstein-Barr Virus Infections (1) · Fever (1) · Headache (1) · Hypertension (1) · Hyperventilation (1) · Hypoxia (1) · Inflammation (1) · Lymphoma (1) · Neoplasms (1) · Pharyngitis (1) · Rhinorrhea (1)
Aga Khan University (1) · Alexandria University (1) · Applied Biological Laboratories Inc (1) · Dr. Jean-Sebastien Delisle, MD, PhD (1) · GERCOR - Multidisciplinary Oncology Cooperative Group (1) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (1) · Ziauddin University (1)
Pakistan (2) · Canada (1) · Egypt (1) · France (1) · United States (1)
Asma Abdus Salam, Consultant anaesthesiology (1) · Benoist Chibaudel, MD (1) · Hongying Yang, MD (1) · Jean-Sebastien Delisle, MD,PhD (1) · Nazlie Latefi, PhD (1) · Rehana Rehman, PhD (1)
PMID 10492412, PMID 10793602, PMID 12717123, PMID 1356374, PMID 17893459, PMID 20576632, PMID 22091288, PMID 23372884, PMID 29261883, PMID 30573962, PMID 34667360, PMID 3605668, PMID 37139057, PMID 39602479, PMID 40804365, PMID 6161627, PMID 9366929, PMID 9793671, PMID 9797517